Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Radiomedix
Radiomedix
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Gallium ga 68 gozetotide
Gallium
2026-06-08
Positron-emission tomography
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Gallium oxodotreotide ga-68
papillary thyroid cancer
,
small cell lung carcinoma
,
ganglioneuroma
,
glioblastoma
,
connective tissue neoplasms
,
ganglioneuroblastoma
,
mesenchymoma
,
thyroid diseases
,
nasopharyngeal carcinoma
,
kidney neoplasms
,
nasopharyngeal neoplasms
,
neuroblastoma
,
carcinoid tumor
,
neoplasms
,
pheochromocytoma
,
prostatic neoplasms
,
pancreatic neoplasms
,
osteomalacia
,
thyroid neoplasms
,
von hippel-lindau disease
,
head and neck neoplasms
,
islet cell adenoma
,
multiple endocrine neoplasia type 1
,
multiple endocrine neoplasia
,
primitive neuroectodermal tumors
,
cushing syndrome
,
carcinoma
,
hepatocellular carcinoma
,
positron-emission tomography
,
somatostatinoma
,
castration-resistant prostatic neoplasms
,
apudoma
,
parathyroid neoplasms
,
hyperparathyroidism
,
hypercalcemia
,
hypertension
,
squamous cell carcinoma of head and neck
,
diagnostic techniques and procedures
,
diagnostic imaging
,
pituitary acth hypersecretion
,
liver neoplasms
,
neoplasm metastasis
,
endocarditis
,
adenocarcinoma
,
healthy volunteers/patients
,
neuroendocrine tumors
,
neuroendocrine carcinoma
,
atherosclerosis
,
endocrine gland neoplasms
,
coronary artery disease
,
breast neoplasms
,
glioma
,
myocardial ischemia
,
pituitary diseases
,
arteriosclerosis
,
hypersensitivity
,
paraganglioma
,
meningioma
,
medulloblastoma
,
pituitary neoplasms
,
sarcoidosis
,
olfactory esthesioneuroblastoma
,
central nervous system neoplasms
,
hemangioblastoma
,
cardiovascular diseases
,
medullary carcinoma
,
inflammation
,
heart diseases
,
myocarditis
,
brain neoplasms
,
myocardial infarction
,
infarction
,
intestinal neoplasms
,
cardiomyopathies
,
insulinoma
,
merkel cell carcinoma
,
vipoma
,
brain stem neoplasms
,
gastrinoma
,
glucagonoma
,
recurrence
,
gliosarcoma
,
solitary fibrous tumors
,
acoustic neuroma
,
ependymoma
,
ewing sarcoma
,
astrocytoma
,
choroid plexus neoplasms
,
craniopharyngioma
,
optic nerve glioma
,
oligodendroglioma
,
primitive neuroectodermal tumors peripheral
,
pinealoma
,
neuroepithelial neoplasms
,
hemangiopericytoma
,
subependymal glioma
,
neuroectodermal tumors
,
neurilemmoma
,
adamantinoma
,
hypercholesterolemia
,
carotid stenosis
,
hyperlipoproteinemia type ii
,
positron emission tomography computed tomography
,
covid-19
,
stroke
,
transient ischemic attack
,
acute coronary syndrome
,
stable angina
,
follicular adenocarcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
stomach neoplasms
,
neurodegenerative diseases
,
disease
,
fabry disease
,
radiotherapy
,
prostatic hyperplasia
,
sarcoma
,
coronary artery bypass
,
graft rejection
,
ischemia
,
peripheral arterial disease
,
chronic limb-threatening ischemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use